English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, November 20, 2019
Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate SM03 Phase III Clinical Trial for the Treatment RA
Monday, November 11, 2019
中国抗体(3681.HK):商业化进程未来可期
中國抗體(3681.HK):商業化進程未來可期
Wednesday, October 30, 2019
中国抗体制药宣布于港交所主板上市计划
中國抗體製藥宣佈於港交所主板上市計劃
SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575